SCHEMBL5313277

SCHEMBL5313277

O=Cc1cccc(-c2n[nH]c3cccc(Cc4ccccc4)c23)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK1 P28482 3/20 0.35
MAPK10 P53779 3/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPK8 P45983 2/20 0.35
MAPK9 P45984 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TTK P33981 2/20 0.35
CDC7 O00311 1/20 0.35
PLK4 O00444 1/20 0.35
CHEK1 O14757 1/20 0.35
IKBKB O14920 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5314638 0.81 MAP2K4 (0.43) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL27530793 0.76 LRRK2 (0.54) CYP3A4CYP1A2CYP2D6MAPK1MAPK10
SCHEMBL5314981 0.75 CYP1A2 (0.34) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8472628 0.75 CYP3A4 (0.40) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7492078 0.72 MAP2K4 (0.59) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL5317261 0.71 CYP1A2 (0.41) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL5315808 0.70 CYP1A2 (0.48) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6854925 0.70 GAA (0.51) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1899541 0.70 CYP1A2 (0.48) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8329288 0.69 PDE5A (0.40) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007065010-A2 ANTI-ANGIOGENESIS COMPOUNDS HIF BIO, INC. (US) 2007-06-07 WO disclosed
EP-0934311-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER AG (DE) 1999-08-11 EP disclosed
WO-1998016507-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO disclosed